Approval · Notice of Compliance 9090 · 2007
VASERETIC: Notice of Compliance 9090
Issued October 15, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9090
- Date
- October 15, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product labelling
- Therapeutic class
- Angiotensin converting enzyme inhibitor and diuretic
Products in this notice
Medicinal ingredients
- ENALAPRIL SODIUM 4 MG per TAB
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- ENALAPRIL SODIUM 8 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB